Nanoparticle targeting of Gram-positive and Gram-negative bacteria for magnetic-based separations of bacterial pathogens

Applied Nanoscience (Switzerland)

Volumn 7, Issue 3-4, 2017, Pages 83-93

  Lu, Hoang D ^a   Yang, Shirley S ^a   Wilson, Brian K ^a   McManus, Simon A ^a   Chen, Christopher V H H ^a   Prud’homme, Robert K ^a  

^a Princeton University   (United States)

Author keywords

Antimicrobial resistance; Bacteria; Filtering; Magnetic separations; Nanoparticle; Targeting

Indexed keywords

BACTERIA; BLOCK COPOLYMERS; FILTRATION; IRON OXIDES; MAGNETIC BUBBLES; MAGNETIC SEPARATION; NANOMAGNETICS; NANOPARTICLES; SELF ASSEMBLY; SOLS; ZINC COMPOUNDS;

ANTIMICROBIAL RESISTANCES; DIRECTED SELF-ASSEMBLY; GRAM-NEGATIVE BACTERIA; MAGNETIC MANIPULATION; NANOPARTICLE TARGETING; PATHOGEN IDENTIFICATION; TARGETED NANOPARTICLE; TARGETING;

TARGETED DRUG DELIVERY;

EID: 85020737633     PISSN: 21905509     EISSN: 21905517     Source Type: Journal    
DOI: 10.1007/s13204-017-0548-0     Document Type: Article

References (46)

1. Allen TM (2002) Ligand-targeted therapeutics in anticancer therapy. Nat Rev Cancer 2:750–763. doi:10.1038/nrc903
2. Bartlett JG, Gilbert DN, Spellberg B (2013) Seven ways to preserve the miracle of antibiotics. Clin Infect Dis 56:1445–1450. doi:10.1093/cid/cit070
3. Brown L, Wolf JM, Prados-Rosales R, Casadevall A (2015) Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi. Nat Rev Microbiol 13:620–630. doi:10.1038/nrmicro3480
4. Cabral H et al (2011) Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. Nat Nanotechnol 6:815–823. doi:10.1038/nnano.2011.166
5. Centers for Disease Control and Prevention (2013) Antibiotic Resistance Threats in the United States
6. Cheng Z, Al Zaki A, Hui JZ, Muzykantov VR, Tsourkas A (2012) Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities. Science 338:903–910. doi:10.1126/science.1226338
7. Choi SK et al (2013) Dendrimer-based multivalent vancomycin nanoplatform for targeting the drug-resistant bacterial surface. ACS Nano 7:214–228. doi:10.1021/nn3038995
8. D’Addio SM et al (2012) Effects of block copolymer properties on nanocarrier protection from in vivo clearance. J Control Release 162:208–217. doi:10.1016/j.jconrel.2012.06.020
9. D’Addio SM et al (2013) Optimization of cell receptor-specific targeting through multivalent surface decoration of polymeric nanocarriers. J Control Release 168:41–49. doi:10.1016/j.jconrel.2013.02.004
10. Elias DR, Poloukhtine A, Popik V, Tsourkas A (2013) Effect of ligand density, receptor density, and nanoparticle size on cell targeting. Nanomed Nanotechnol Biol Med 9:194–201. doi:10.1016/j.nano.2012.05.015
11. Falagas ME, Grammatikos AP, Michalopoulos A (2008) Potential of old-generation antibiotics to address current need for new antibiotics. Expert Rev Anti Infect Ther 6:593–600. doi:10.1586/14787210.6.5.593
12. Hanshaw RG, Smith BD (2005) New reagents for phosphatidylserine recognition and detection of apoptosis. Bioorg Med Chem 13:5035–5042. doi:10.1016/j.bmc.2005.04.071
13. Holmes AH, Moore LSP, Steinbakk M, Regmi S, Karkey A, Guerin PJ, Piddock LJV (2016) Understanding the mechanisms and drivers of antimicrobial resistance. Lancet 387:176–187
14. Johnson BK, Prud’homme RK (2003a) Flash nanoprecipitation of organic actives and block copolymers using a confined impinging jets mixer. Aust J Chem 56:1021–1024
15. Johnson BK, Prud’homme RK (2003b) Mechanism for rapid self-assembly of block copolymer nanoparticles. Phys Rev Lett 91:118302
16. Kathleen MM, Ananth A, Ravi VB (2007) Decreased circulation time offsets increased efficacy of PEGylated nanocarriers targeting folate receptors of glioma. Nanotechnology 18:385101
17. Kell AJ et al (2008) Vancomycin-modified nanoparticles for efficient targeting and preconcentration of Gram-positive and Gram-negative bacteria. ACS Nano 2:1777–1788. doi:10.1021/nn700183g
18. Lee H, Fonge H, Hoang B, Reilly RM, Allen C (2010) The effects of particle size and molecular targeting on the intratumoral and subcellular distribution of polymeric nanoparticles. Mol Pharm 7:1195–1208. doi:10.1021/mp100038h
19. Lee JJ et al (2014) Synthetic ligand-coated magnetic nanoparticles for microfluidic bacterial separation from blood. Nano Lett 14:1–5. doi:10.1021/nl3047305
20. Lu HD et al (2015) Modulating Vibrio cholerae quorum-sensing-controlled communication using autoinducer-loaded nanoparticles. Nano Lett 15:2235–2241. doi:10.1021/acs.nanolett.5b00151
21. Lu HD, Wilson BK, Heinmiller A, Faenza B, Hejazi S, Prud’homme RK (2016) Narrow absorption NIR wavelength organic nanoparticles enable multiplexed photoacoustic imaging. ACS Appl Mater Interfaces 8:14379–14388. doi:10.1021/acsami.6b03059
22. Lu HD, Wilson BK, Lim TL, Heinmiller A, Prud'homme RK (2017) Real-time and multiplexed photoacoustic imaging of internally normalized mixed-targeted nanoparticles. ACS Biomater Sci Eng. doi:10.1021/acsbiomaterials.6b00645
23. Osterberg L, Blaschke T (2005) Adherence to medication. N Engl J Med 353:487–497. doi:10.1056/NEJMra050100
24. Pansare VJ, Hejazi S, Faenza WJ, Prud’homme RK (2012) Review of long-wavelength optical and NIR imaging materials: contrast agents, fluorophores, and multifunctional nano carriers. Chem Mater 24:812–827. doi:10.1021/cm2028367
25. Pansare VJ, Bruzek MJ, Adamson DH, Anthony J, Prud’homme RK (2014) Composite fluorescent nanoparticles for biomedical imaging. Mol Imaging Biol 16:180–188. doi:10.1007/s11307-013-0689-9
26. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R (2007) Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2:751–760. doi:10.1038/nnano.2007.387
27. Piddock LJV (2012) The crisis of no new antibiotics—what is the way forward? Lancet Infect Dis 12:249–253. doi:10.1016/S1473-3099(11)70316-4
28. Plaunt AJ, Harmatys KM, Wolter WR, Suckow MA, Smith BD (2014) Library synthesis, screening, and discovery of modified zinc(II)-Bis(dipicolylamine) probe for enhanced molecular imaging of cell death. Bioconjug Chem 25:724–737. doi:10.1021/bc500003x
29. Pustulka KM et al (2013) Flash nanoprecipitation: particle structure and stability. Mol Pharm 10:4367–4377. doi:10.1021/mp400337f
30. Rice DR, Gan H, Smith BD (2015) Bacterial imaging and photodynamic inactivation using zinc(II)-dipicolylamine BODIPY conjugates. Photochem Photobiol Sci 14:1271–1281. doi:10.1039/C5PP00100E
31. Shen H, Hong S, Prud’homme RK, Liu Y (2011) Self-assembling process of flash nanoprecipitation in a multi-inlet vortex mixer to produce drug-loaded polymeric nanoparticles. J Nanopart Res 13:4109–4120. doi:10.1007/s11051-011-0354-7
32. Silhavy TJ, Kahne D, Walker S (2010) The bacterial cell envelope. Cold Spring Harb Perspect Biol 2:a000414. doi:10.1101/cshperspect.a000414
33. Singh R, Lillard JW (2009) Nanoparticle-based targeted drug delivery. Exp Mol Pathol 86:215–223. doi:10.1016/j.yexmp.2008.12.004
34. van Oosten M et al (2013) Real-time in vivo imaging of invasive- and biomaterial-associated bacterial infections using fluorescently labelled vancomycin. Nat Commun 4:2584. doi:10.1038/ncomms3584
35. van Oosten M, Hahn M, Crane LMA, Pleijhuis RG, Francis KP, van Dijl JM, van Dam GM (2015) Targeted imaging of bacterial infections: advances, hurdles and hopes. FEMS Microbiol Rev 39:892–916. doi:10.1093/femsre/fuv029
36. Ventola CL (2015a) The antibiotic resistance crisis. Part 1: Causes and threats. Pharm Ther 40:277–283
37. Ventola CL (2015b) The antibiotic resistance crisis. Part 2: Management strategies and new agents. Pharm Ther 40:344–352
38. Viswanathan VK (2014) Off-label abuse of antibiotics by bacteria. Gut Microbes 5:3–4
39. Wang L, Sun X, Du L, Yuan Q, Li H, Tian H, Li Y (2011) Effects and patient compliance of sustained-release versus immediate-release glipizides in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. J Evid Based Med 4:232–241. doi:10.1111/j.1756-5391.2011.01158.x
40. Weissmueller NT, Lu HD, Hurley A, Prud’homme RK (2016) Nanocarriers from GRAS zein proteins to encapsulate hydrophobic actives. Biomacromolecules. doi:10.1021/acs.biomac.6b01440
41. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB (2004) Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39:309–317
42. Wong PT et al (2015) A lipopolysaccharide binding heteromultivalent dendrimer nanoplatform for Gram negative cell targeting. J Mater Chem B 3:1149–1156. doi:10.1039/C4TB01690D
43. World Health Organization (2015) Antimicrobial resistance
44. Zhang L, Gu FX, Chan JM, Wang AZ, Langer RS, Farokhzad OC (2008) Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther 83:761–769
45. Zhang L, Pornpattananangku D, Hu CMJ, Huang CM (2010) Development of nanoparticles for antimicrobial drug delivery. Curr Med Chem 17:585–594
46. Zhu Z (2014) Flash nanoprecipitation: prediction and enhancement of particle stability via drug structure. Mol Pharm 11:776–786. doi:10.1021/mp500025e